4.5 Review

Challenges with the discovery of RNA-based therapeutics for flaviviruses

Related references

Note: Only part of the references are listed.
Article Biotechnology & Applied Microbiology

sEVsRVG selectively delivers antiviral siRNA to fetus brain, inhibits ZIKV infection and mitigates ZIKV- induced in mouse model

Rui Zhang et al.

Summary: The research team has developed a targeted antiviral therapy system based on sEVs to combat ZIKV-induced neurological disorders and fetal brain infections. This system utilizes specific siRNA and neuron-targeting proteins, effectively preventing infection in fetal mouse brains and alleviating neuroinflammation and neurological damage caused by ZIKV.

MOLECULAR THERAPY (2022)

Article Biotechnology & Applied Microbiology

Lyophilization provides long-term stability for a lipid nanoparticle-formulated , nucleoside-modified mRNA vaccine

Hiromi Muramatsu et al.

Summary: Research demonstrates that nucleoside-modified mRNA-LNP vaccines can be lyophilized and maintain their physicochemical properties after storage at room temperature for 12 weeks or at 4℃ for at least 24 weeks. Comparative studies also show that lyophilized mRNA-LNP vaccines maintain high expression and immunogenicity even after storage.

MOLECULAR THERAPY (2022)

Article Chemistry, Multidisciplinary

Development of a high-throughput platform for screening lipid nanoparticles for mRNA delivery

Lili Cui et al.

Summary: This article introduces an automated high-throughput screening platform for selecting novel ionisable lipids and LNPs encapsulating mRNA. The platform allows efficient and precise preparation of LNPs and has been successfully used to screen for novel mRNA LNP leads.

NANOSCALE (2022)

Review Genetics & Heredity

Drug delivery systems for RNA therapeutics

Kalina Paunovska et al.

Summary: This article provides an overview of the importance of RNA-based gene therapy and describes the molecular mechanisms of RNA therapies and different drug delivery systems. It also discusses the path from preclinical research to clinical approval for these therapies.

NATURE REVIEWS GENETICS (2022)

Article Biochemistry & Molecular Biology

TMEM41B Is a Pan-flavivirus Host Factor

H. Heinrich Hoffmann et al.

Summary: Flaviviruses pose a constant threat to human health, being transmitted by infected mosquitoes and ticks, and causing regular outbreaks. Through full-genome loss of function CRISPR-Cas9 screens, TMEM41B and VMP1 were identified as key factors in flavivirus infection. TMEM41B was found to be essential for all tested members of the Flaviviridae family, as well as for SARS-CoV-2 of the Coronaviridae. Single nucleotide polymorphisms in nearly 20% of East Asian populations were shown to reduce flavivirus infection.
Article Chemistry, Medicinal

Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents

Tommaso Felicetti et al.

Summary: A sustainable three-component reaction (3CR) was developed for synthesizing PBTZ analogues with broad-spectrum anti-flavivirus activity, with compound 22 identified as the best inhibitor in a new series. These results support PBTZ derivatives as promising anti-flavivirus agents for further development studies.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Multidisciplinary Sciences

A broadly protective antibody that targets the flavivirus NS1 protein

Naphak Modhiran et al.

Summary: The NS1 antibody 1G5.3 can effectively block NS1-mediated cell permeability of multiple flaviviruses, reduce viremia, and improve survival in various animal models. The protective effect of 1G5.3 is independent of effector function, making it a key site for broad-spectrum antiviral development.

SCIENCE (2021)

Article Multidisciplinary Sciences

A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction

Suzanne J. F. Kaptein et al.

Summary: JNJ-A07 is a highly potent inhibitor of dengue virus, showing nanomolar to picomolar activity against a panel of 21 clinical isolates. It prevents the formation of viral replication complex by blocking the interaction between NS3 and NS4B proteins, revealing a previously undescribed mechanism of antiviral action. The molecule has a favorable pharmacokinetic profile and exhibits outstanding efficacy in mouse infection models, even when treatment is initiated at peak viraemia.

NATURE (2021)

Review Biochemistry & Molecular Biology

Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs

Dharma Rao Tompa et al.

Summary: Infections caused by microscopic viruses can lead to chronic illnesses like HIV/AIDS, flu, etc. Developing new and superior antiviral drugs is crucial, but the drugs can be toxic to human cells and viruses can develop resistance. Combination drugs targeting viral replication are common, but innovative strategies are needed to combat emerging viruses like Ebola and coronaviruses.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)

Review Virology

Flavivirus Persistence in Wildlife Populations

Maria Raisa Blahove et al.

Summary: Research on vector-borne flavivirus persistence in wildlife emphasizes the critical roles of non-structural proteins in viral persistence, the development of animal models, and the study of host factors enabling viral replication without destructive effects. These findings contribute to understanding the mechanisms underlying viral persistence in wildlife.

VIRUSES-BASEL (2021)

Article Chemistry, Organic

Enhanced target cell specificity and uptake of lipid nanoparticles using RNA aptamers and peptides

Roslyn M. Ray et al.

Summary: This study demonstrates the potential of using RNA aptamer-loaded LNPs to facilitate crossing the blood-brain barrier, increase target cell specificity, and potentially deliver drugs to central nervous system tissues.

BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases

Rita M. Meganck et al.

Summary: The emphasis on developing broadly effective antiviral family-specific and cross-family therapies is crucial in preparing for future disease outbreaks, requiring proactive research on outbreak-prone virus families.

NATURE MEDICINE (2021)

Article Medicine, General & Internal

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

Sander F. Garrelfs et al.

Summary: Primary hyperoxaluria type 1 is a rare genetic disease caused by hepatic overproduction of oxalate, leading to kidney stones, nephrocalcinosis, kidney failure, and systemic oxalosis. This trial tested the efficacy of lumasiran, an RNAi therapeutic agent, in reducing hepatic oxalate production. The results showed that lumasiran significantly reduced urinary oxalate excretion, alleviating the cause of kidney failure in PH1 patients.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

Structures of flavivirus RNA promoters suggest two binding modes with NS5 polymerase

Eunhye Lee et al.

Summary: Flaviviruses use stem-loop A (SLA) as a promoter for RNA synthesis, with NS5 recognizing SLA to initiate RNA synthesis. The crystal structures of DENV and ZIKV SLAs show differences in orientation, but these can be compensated by differences in domain arrangements in DENV and ZIKV NS5s.

NATURE COMMUNICATIONS (2021)

Review Biotechnology & Applied Microbiology

The Limitless Future of RNA Therapeutics

Tulsi Ram Damase et al.

Summary: Recent advances in RNA technology have enabled the development of RNA-based therapeutics, which are cost-effective, relatively simple to manufacture, and can target previously undruggable pathways. These drugs have the potential to change the standard of care for many diseases and actualize personalized medicine. Challenges and advantages associated with RNA-based drugs are discussed along with various approaches for RNA delivery.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)

Article Chemistry, Multidisciplinary

Sphingosine 1-Phosphate Liposomes for Targeted Nitric Oxide Delivery to Mediate Anticancer Effects against Brain Glioma Tumors

Yang Liu et al.

Summary: The study describes a liposome drug delivery system that targets glioblastoma multiforme (GBM) blood vessels and enhances the permeability of the brain-blood-tumor barrier (BBTB). This system successfully delivers a nitric oxide prodrug to GBM tumors, showing promise for targeted therapies against GBM and other cancers characterized by elevated S1PR expression.

ADVANCED MATERIALS (2021)

Article Biotechnology & Applied Microbiology

Noncoding RNA therapeutics - challenges and potential solutions

Melanie Winkle et al.

Summary: In recent years, RNA-based therapies have gained FDA approval, but there are still challenges in targeting ncRNAs. Therapeutic targeting of noncoding RNAs has the potential to become a new approach for treating diseases such as cancer.

NATURE REVIEWS DRUG DISCOVERY (2021)

Review Immunology

A review: Mechanism of action of antiviral drugs

Shamaila Kausar et al.

Summary: Antiviral drugs are a class of medicines used to treat viral infections, with strategies focusing on targeting the viruses themselves or host cell factors. Viruses can cause various serious diseases in humans, animals, and plants, and the action mechanism of antiviral drugs includes inhibiting viral nucleic acid synthesis and enhancing cell resistance to viruses.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2021)

Article Multidisciplinary Sciences

Flavivirus induces and antagonizes antiviral RNA interference in both mammals and mosquitoes

Yang Qiu et al.

SCIENCE ADVANCES (2020)

Article Biochemistry & Molecular Biology

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza

Timothy R. Abbott et al.

Article Chemistry, Medicinal

Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase

Rolando Cannalire et al.

ACS MEDICINAL CHEMISTRY LETTERS (2020)

Article Multidisciplinary Sciences

In vivo biodistribution analysis of transmission competent and defective RNA virus-based episomal vector

Yumiko Komatsu et al.

SCIENTIFIC REPORTS (2020)

Review Microbiology

The continued threat of emerging flaviviruses

Theodore C. Pierson et al.

NATURE MICROBIOLOGY (2020)

Article Biotechnology & Applied Microbiology

siRNA Design to Silence the 3′UTR Region of Zika Virus

Maria Perez-Mendez et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Review Chemistry, Medicinal

Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View

Tommaso Felicetti et al.

CHEMMEDCHEM (2020)

Review Biotechnology & Applied Microbiology

The current state and future directions of RNAi-based therapeutics

Ryan L. Setten et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Article Chemistry, Medicinal

Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo

Culling Zhang et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2019)

Article Microbiology

An RNA-centric dissection of host complexes controlling flavivirus infection

Yaw Shin Ooi et al.

NATURE MICROBIOLOGY (2019)

Article Chemistry, Multidisciplinary

On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA

Jayesh A. Kulkarni et al.

ACS NANO (2018)

Editorial Material Microbiology

Turning Up Your Nose for a Flaviviral Encephalitis Cure

Rina Barouch-Bentov et al.

CELL HOST & MICROBE (2018)

Article Chemistry, Multidisciplinary

Injectable and protease-degradable hydrogel for siRNA sequestration and triggered delivery to the heart

Leo L. Wang et al.

JOURNAL OF CONTROLLED RELEASE (2018)

Article Medicine, General & Internal

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

D. Adams et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Medicine, General & Internal

Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

E. Mercuri et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Multidisciplinary Sciences

Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity

Maja M. Janas et al.

NATURE COMMUNICATIONS (2018)

Article Medicine, Research & Experimental

Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1

Jiehua Zhou et al.

THERANOSTICS (2018)

Article Pharmacology & Pharmacy

Development of an Alcohol Dilution-Lyophilization Method for Preparing Lipid Nanoparticles Containing Encapsulated siRNA

Daiki Shirane et al.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2018)

Review Multidisciplinary Sciences

The emergence of Zika virus and its new clinical syndromes

Theodore C. Pierson et al.

NATURE (2018)

Article Virology

Vivo-morpholino oligomers strongly inhibit dengue virus replication and production

Patta Phumesin et al.

ARCHIVES OF VIROLOGY (2018)

Article Biotechnology & Applied Microbiology

Development of RNA aptamer that inhibits methyltransferase activity of dengue virus

Jae In Jung et al.

BIOTECHNOLOGY LETTERS (2018)

Article Nanoscience & Nanotechnology

Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization

Rebecca L. Ball et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)

Article Biochemistry & Molecular Biology

Visualization of self-delivering hydrophobically modified siRNA cellular internalization

Socheata Ly et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Immunology

Zika Virus Mosquito Vectors: Competence, Biology, and Vector Control

Elizabeth B. Kauffman et al.

JOURNAL OF INFECTIOUS DISEASES (2017)

Article Medicine, Research & Experimental

In Situ Gelling Liquid Crystalline System as Local siRNA Delivery System

Livia N. Borgheti-Cardoso et al.

MOLECULAR PHARMACEUTICS (2017)

Article Biotechnology & Applied Microbiology

Clinical Proof of Concept for a Novel Hepatocyte-Targeting GaINAc-siRNA Conjugate

Tracy S. Zimmermann et al.

MOLECULAR THERAPY (2017)

Article Medicine, General & Internal

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

R. S. Finkel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Biochemistry & Molecular Biology

Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc-siRNA conjugates

Jayaprakash K. Nair et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Biochemistry & Molecular Biology

Antisense Oligonucleotides Targeting Raf-1 Block Japanese Encephalitis Virus In Vitro and In Vivo

Li Zhang et al.

NUCLEIC ACID THERAPEUTICS (2017)

Review Genetics & Heredity

Advances in the delivery of RNA therapeutics: from concept to clinical reality

James C. Kaczmarek et al.

GENOME MEDICINE (2017)

Article Pharmacology & Pharmacy

The FDA-approved drug sofosbuvir inhibits Zika virus infection

Kristen M. Bullard-Feibelman et al.

ANTIVIRAL RESEARCH (2017)

Article Biochemistry & Molecular Biology

Inhibition of Japanese encephalitis virus (JEV) replication by specific RNA aptamer against JEV methyltransferase

Seung Ryul Han et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Article Chemistry, Multidisciplinary

Self-Assembled Wound Dressings Silence MMP-9 and Improve Diabetic Wound Healing In Vivo

Steven A. Castleberry et al.

ADVANCED MATERIALS (2016)

Review Biotechnology & Applied Microbiology

Precise and efficient siRNA design: a key point in competent gene silencing

E. Fakhr et al.

CANCER GENE THERAPY (2016)

Article Chemistry, Multidisciplinary

Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles

Tsukasa Sugo et al.

JOURNAL OF CONTROLLED RELEASE (2016)

Article Multidisciplinary Sciences

Yellow fever virus capsid protein is a potent suppressor of RNA silencing that binds double-stranded RNA

Glady Hazitha Samuel et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Multidisciplinary Sciences

Enhancing Endosomal Escape for Intracellular Delivery of Macromolecular Biologic Therapeutics

Peter Lonn et al.

SCIENTIFIC REPORTS (2016)

Article Otorhinolaryngology

The blood-brain barrier and nasal drug delivery to the central nervous system

Marcel Menon Miyake et al.

AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2015)

Review Pathology

Engineered In Vitro Disease Models

Kambez H. Benam et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10 (2015)

Review Pharmacology & Pharmacy

The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development

Dahai Luo et al.

ANTIVIRAL RESEARCH (2015)

Article Biochemistry & Molecular Biology

Dengue NS3, an RNAi suppressor, modulates the human miRNA pathways through its interacting partner

Pavan Kumar Kakumani et al.

BIOCHEMICAL JOURNAL (2015)

Article Pharmacology & Pharmacy

Solid lipid nanoparticles as non-viral vector for the treatment of chronic hepatitis C by RNA interference

Josune Torrecilla et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)

Article Virology

Yellow fever

Thomas P. Monath et al.

JOURNAL OF CLINICAL VIROLOGY (2015)

Article Biotechnology & Applied Microbiology

Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown

Anders Wittrup et al.

NATURE BIOTECHNOLOGY (2015)

Article Genetics & Heredity

Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study

Ole B. Suhr et al.

ORPHANET JOURNAL OF RARE DISEASES (2015)

Article Materials Science, Biomaterials

Molecular Tuning of a Vitamin E-Scaffold pH-Sensitive and Reductive Cleavable Lipid-like Material for Accelerated in Vivo Hepatic siRNA Delivery

Hidetaka Akita et al.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2015)

Article Materials Science, Biomaterials

Molecular Tuning of a Vitamin E-Scaffold pH-Sensitive and Reductive Cleavable Lipid-like Material for Accelerated in Vivo Hepatic siRNA Delivery

Hidetaka Akita et al.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2015)

Article Virology

Characterization of the Mode of Action of a Potent Dengue Virus Capsid Inhibitor

Pietro Scaturro et al.

JOURNAL OF VIROLOGY (2014)

Review Biotechnology & Applied Microbiology

Gold Nanoparticles for Nucleic Acid Delivery

Ya Ding et al.

MOLECULAR THERAPY (2014)

Review Multidisciplinary Sciences

Organogenesis in a dish: Modeling development and disease using organoid technologies

Madeline A. Lancaster et al.

SCIENCE (2014)

Article Biochemical Research Methods

Aptamer Displacement Screen for Flaviviral RNA Methyltransferase Inhibitors

Shaun P. Falk et al.

JOURNAL OF BIOMOLECULAR SCREENING (2014)

Article Clinical Neurology

Eteplirsen for the Treatment of Duchenne Muscular Dystrophy

Jerry R. Mendell et al.

ANNALS OF NEUROLOGY (2013)

Article Microbiology

A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein

Chelsea M. Byrd et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)

Article Cell Biology

Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice

Laura Soucek et al.

GENES & DEVELOPMENT (2013)

Article Biotechnology & Applied Microbiology

Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape

Jerome Gilleron et al.

NATURE BIOTECHNOLOGY (2013)

Article Biotechnology & Applied Microbiology

Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling

Gaurav Sahay et al.

NATURE BIOTECHNOLOGY (2013)

Article Biochemistry & Molecular Biology

Differential roles of human Dicer-binding proteins TRBP and PACT in small RNA processing

Ho Young Lee et al.

NUCLEIC ACIDS RESEARCH (2013)

Article Biochemistry & Molecular Biology

Inhibition of Dengue Virus 2 Replication by Artificial MicroRNAs Targeting the Conserved Regions

Pei-wen Xie et al.

NUCLEIC ACID THERAPEUTICS (2013)

Article Chemistry, Multidisciplinary

Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo

Muthusamy Jayaraman et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)

Article Microbiology

Liposome-Mediated Delivery of Iminosugars Enhances Efficacy against Dengue Virus In Vivo

Joanna L. Miller et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)

Review Chemistry, Multidisciplinary

Endocytosis at the nanoscale

Irene Canton et al.

CHEMICAL SOCIETY REVIEWS (2012)

Article Pharmacology & Pharmacy

Solid lipid nanoparticles as intracellular drug transporters: An investigation of the uptake mechanism and pathway

S. Martins et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)

Article Microbiology

Small-Molecule Inhibitors of Dengue-Virus Entry

Aaron G. Schmidt et al.

PLOS PATHOGENS (2012)

Article Medicine, Research & Experimental

Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA

Nathan M. Belliveau et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2012)

Review Immunology

Pathogen Recognition by the Innate Immune System

Himanshu Kumar et al.

INTERNATIONAL REVIEWS OF IMMUNOLOGY (2011)

Article Biotechnology & Applied Microbiology

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

Lydia Alvarez-Erviti et al.

NATURE BIOTECHNOLOGY (2011)

Article Biochemistry & Molecular Biology

Targeting of highly conserved Dengue virus sequences with anti-Dengue virus trans-splicing group I introns

James R. Carter et al.

BMC MOLECULAR BIOLOGY (2010)

Review Microbiology

Viral Suppressors of RNA-Based Viral Immunity: Host Targets

Qingfa Wu et al.

CELL HOST & MICROBE (2010)

Article Virology

RNA Structures Required for Production of Subgenomic Flavivirus RNA

Anneke Funk et al.

JOURNAL OF VIROLOGY (2010)

Article Biotechnology & Applied Microbiology

Noninvasive Imaging of Lipid Nanoparticle-Mediated Systemic Delivery of Small-Interfering RNA to the Liver

Weikang Tao et al.

MOLECULAR THERAPY (2010)

Article Biotechnology & Applied Microbiology

Rational design of cationic lipids for siRNA delivery

Sean C. Semple et al.

NATURE BIOTECHNOLOGY (2010)

Article Multidisciplinary Sciences

A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

John DeVincenzo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Multidisciplinary Sciences

Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection

Robert E. Lanford et al.

SCIENCE (2010)

Article Pharmacology & Pharmacy

A small molecule fusion inhibitor of dengue virus

Mee Kian Poh et al.

ANTIVIRAL RESEARCH (2009)

Article Biochemical Research Methods

BLAST plus : architecture and applications

Christiam Camacho et al.

BMC BIOINFORMATICS (2009)

Article Genetics & Heredity

RNA interference inhibits yellow fever virus replication in vitro and in vivo

Carolina C. Pacca et al.

VIRUS GENES (2009)

Article Multidisciplinary Sciences

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3

Mark E. Kleinman et al.

NATURE (2008)

Article Biotechnology & Applied Microbiology

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

Akin Akinc et al.

NATURE BIOTECHNOLOGY (2008)

Review Biotechnology & Applied Microbiology

RNA interference against viruses: strike and counterstrike

Joost Haasnoot et al.

NATURE BIOTECHNOLOGY (2007)

Article Chemistry, Multidisciplinary

Octaarginine-modified multifunctional envelope-type nano device for siRNA

Yoshio Nakamura et al.

JOURNAL OF CONTROLLED RELEASE (2007)

Article Biotechnology & Applied Microbiology

RNase H-mediated retrovirus destruction in vivo triggered by oligodeoxynucleotides

Kathrin Matzen et al.

NATURE BIOTECHNOLOGY (2007)

Article Biotechnology & Applied Microbiology

Silencing of HIV-1 with RNA interference: A multiple shRNA approach

Olivier ter Brake et al.

MOLECULAR THERAPY (2006)

Article Multidisciplinary Sciences

RNAi-mediated gene silencing in non-human primates

TS Zimmermann et al.

NATURE (2006)

Article Biotechnology & Applied Microbiology

Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo

AD Judge et al.

MOLECULAR THERAPY (2006)

Article Medicine, Research & Experimental

Breath actuated device improves delivery to target sites beyond the nasal valve

PG Djupesland et al.

LARYNGOSCOPE (2006)

Article Biotechnology & Applied Microbiology

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

DV Morrissey et al.

NATURE BIOTECHNOLOGY (2005)

Article Immunology

Use of RNA interference to prevent lethal murine West Nile virus infection

FW Bai et al.

JOURNAL OF INFECTIOUS DISEASES (2005)

Article Biochemistry & Molecular Biology

HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome

EM Westerhout et al.

NUCLEIC ACIDS RESEARCH (2005)

Article Biotechnology & Applied Microbiology

Rational siRNA design for RNA interference

A Reynolds et al.

NATURE BIOTECHNOLOGY (2004)

Article Multidisciplinary Sciences

Revealing the world of RNA interference

CC Mello et al.

NATURE (2004)

Article Multidisciplinary Sciences

Inhibition of interferon signaling by dengue virus

JL Muñoz-Jordán et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Virology

Human immunodeficiency virus type 1 escape from RNA interference

D Boden et al.

JOURNAL OF VIROLOGY (2003)

Article Cell Biology

Activation of the interferon system by short-interfering RNAs

CA Sledz et al.

NATURE CELL BIOLOGY (2003)

Article Biochemistry & Molecular Biology

Inhibition of retroviral pathogenesis by RNA interference

WY Hu et al.

CURRENT BIOLOGY (2002)

Article Multidisciplinary Sciences

Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems

NJ Caplen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Multidisciplinary Sciences

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

SM Elbashir et al.

NATURE (2001)

Article Multidisciplinary Sciences

Role for a bidentate ribonuclease in the initiation step of RNA interference

E Bernstein et al.

NATURE (2001)